Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1Breast 1

Conditions

Melanoma 9Neoplasm Metastasis 3Urinary Bladder Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Fallopian Tube Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3cediranib 2temsirolimus 1palbociclib 1montanide ISA 51 1liposomal doxorubicin 1flt3 ligand protein 1entinostat 1Watchful Waiting 1Vorinostat 1Vinorelbine 1Thrombopoietin 1Therapeutics 1Thalidomide 1Stem Cell Factor 1Sirolimus 1SUB1 protein, human 1Radiosurgery 1Psychiatric Rehabilitation 1Propranolol 1Microscopy, Electron 1Mental Status and Dementia Tests 1Interleukin-2 1Immunohistochemistry 1Filgrastim 1Fentanyl 1Docetaxel 1Decitabine 1Cyclophosphamide 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × Decitabine × Dermatologic × Clear all
NCT00030615 2013-02-07

Decitabine in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
BreastDermatologicGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Melanoma, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡